PARIS: A new treatment for a drug-resistant strain of tuberculosis can cure 80 percent of sufferers, according to a trial hailed Monday as a 'game changer' in the fight against the global killer.

Doctors in Belarus—a country with one of the highest rates of multidrug-resistant tuberculosis in the world—spent months treating patients with a new drug, bedaquiline, alongside other antibiotics.